Latest ROE for Lumexa Imaging Holdings Common Stock: -8.01% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-8.01%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for LMRI is -8.01%. That is below the sector sector average of -6.13%. Investors often review this figure alongside Lumexa Imaging Holdings Common Stock's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, LMRI currently prints -8.01% for ROE, while the sector average sits near -6.13%. That is roughly 30.8% below the sector mean. Large gaps often invite a closer look at Lumexa Imaging Holdings Common Stock's growth, margins, and balance sheet.
Return on Equity shows how effectively Lumexa Imaging Holdings Common Stock converts resources into returns. At -8.01%, LMRI may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting LMRI's ROE (-8.01%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.